Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / OnKure Therapeutics, Inc.

OnKure Therapeutics, Inc.

Stage unknownBoulder, COPharmaceuticals
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1
Financing history
1 rounds
  1. Oct 4, 2024
    Form D equity offering · $65.0M (form d sold) · 20 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “OnKure Therapeutics, Inc. filed Form D: $65,000,000 sold of $65,000,000, Pharmaceuticals”
Investors on record
1 edges
People
4 officers, 6 directors
Timeline
1
  1. Oct 21, 2024
    OnKure Therapeutics, Inc. filed Form D: $65,000,000 sold of $65,000,000, Pharmaceuticals
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
16 observations
Every observation on this company